tiprankstipranks
Trending News
More News >
Intellia Therapeutics (NTLA)
NASDAQ:NTLA
US Market

Intellia Therapeutics (NTLA) Income Statement

Compare
4,593 Followers

Intellia Therapeutics Income Statement

Last quarter (Q3 2025), Intellia Therapeutics's total revenue was $13.78M, an increase of 51.27% from the same quarter last year. In Q3, Intellia Therapeutics's net income was $-101.32M. See Intellia Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 57.88M$ 36.27M$ 52.12M$ 33.05M$ 57.99M
Gross Profit
$ 47.59M$ 27.30M$ 44.55M$ 26.16M$ -92.41M
Operating Expenses
$ 581.86M$ 542.59M$ 502.71M$ 294.01M$ 44.17M
Depreciation and Amortization
$ 10.29M$ 8.98M$ 7.57M$ 6.89M$ 6.31M
EBITDA
$ -523.98M$ -506.31M$ -450.59M$ -260.96M$ -130.27M
Operating Income
$ -534.26M$ -515.29M$ -458.16M$ -267.85M$ -136.58M
Other Income/Expenses
$ 15.24M$ 34.10M$ -16.02M$ -42.00K$ 2.35M
Pretax Income
$ -519.02M$ -481.19M$ -474.19M$ -267.89M$ -134.23M
Net Income
$ -519.02M$ -481.19M$ -474.19M$ -267.89M$ -134.23M
Per Share Metrics
Basic EPS
$ -5.25$ -5.42$ -6.16$ -3.78$ -2.40
Diluted EPS
$ -5.25$ -5.42$ -6.16$ -3.78$ -2.40
Weighted Average Shares Outstanding
98.85M 88.77M 76.97M 70.89M 55.99M
Weighted Average Shares Outstanding (Diluted)
98.85M 88.77M 76.97M 70.89M 55.99M
Currency in USD

Intellia Therapeutics Earnings and Revenue History